BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 29231254)

  • 1. Characteristics of pediatric recurrent erythema multiforme.
    Heinze A; Tollefson M; Holland KE; Chiu YE
    Pediatr Dermatol; 2018 Jan; 35(1):97-103. PubMed ID: 29231254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent erythema multiforme: clinical characteristics, etiologic associations, and treatment in a series of 48 patients at Mayo Clinic, 2000 to 2007.
    Wetter DA; Davis MDP
    J Am Acad Dermatol; 2010 Jan; 62(1):45-53. PubMed ID: 19665257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herpes simplex virus-associated erythema multiforme in prepubertal children.
    Weston WL; Morelli JG
    Arch Pediatr Adolesc Med; 1997 Oct; 151(10):1014-6. PubMed ID: 9343012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triggers, clinical manifestations, and management of pediatric erythema multiforme: A systematic review.
    Zoghaib S; Kechichian E; Souaid K; Soutou B; Helou J; Tomb R
    J Am Acad Dermatol; 2019 Sep; 81(3):813-822. PubMed ID: 31331726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paediatric Erythema Multiforme: Epidemiological, Clinical and Laboratory Characteristics.
    Siedner-Weintraub Y; Gross I; David A; Reif S; Molho-Pessach V
    Acta Derm Venereol; 2017 Apr; 97(4):489-492. PubMed ID: 27868144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Childhood postinfectious erythema multiforme].
    Larquey M; Mahé E
    Arch Pediatr; 2016 Nov; 23(11):1184-1190. PubMed ID: 27663464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythema multiforme--etiopathogenic, clinical and therapeutic aspects.
    Creţu A; Dimitriu A; Brănişteanu D; Brinişteanu DE
    Rev Med Chir Soc Med Nat Iasi; 2015; 119(1):55-61. PubMed ID: 25970943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermittent oral cyclosporin for recurrent herpes simplex-associated erythema multiforme.
    Bakis S; Zagarella S
    Australas J Dermatol; 2005 Feb; 46(1):18-20. PubMed ID: 15670172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Erythema multiforme in children versus Stevens-Johnson syndrome].
    Czubkowska I; Barszczak H; Koźniewska D; Wasaznik G
    Wiad Lek; 2000; 53(1-2):43-8. PubMed ID: 10806920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An unusual presentation of erythema multiforme in a paediatric patient.
    BaniHani A; Nazzal H; Webb L; Toumba KJ; Fabbroni G
    Eur Arch Paediatr Dent; 2015 Jun; 16(3):297-302. PubMed ID: 25851963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vesicular Contact Reaction May Progress into Erythema Multiforme.
    Czarnecka-Operacz M; Jenerowicz D; Szulczyńska-Gabor J; Teresiak-Mikołajczak E; Szyfter-Harris J; Bowszyc-Dmochowska M
    Acta Dermatovenerol Croat; 2016 Dec; 24(4):307-309. PubMed ID: 28128086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features, diagnosis, and treatment of erythema multiforme: a review for the practicing dermatologist.
    Sokumbi O; Wetter DA
    Int J Dermatol; 2012 Aug; 51(8):889-902. PubMed ID: 22788803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment by thalidomide of chronic multiforme erythema: its recurrent and continuous variants. A retrospective study of 26 patients].
    Cherouati K; Claudy A; Souteyrand P; Cambazard F; Vaillant L; Moulin G; Crickx B; Morel P; Lamorelle A; Revuz J
    Ann Dermatol Venereol; 1996; 123(6-7):375-7. PubMed ID: 8959059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis, classification, and management of erythema multiforme and Stevens-Johnson syndrome.
    Léauté-Labrèze C; Lamireau T; Chawki D; Maleville J; Taïeb A
    Arch Dis Child; 2000 Oct; 83(4):347-52. PubMed ID: 10999875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent erythema multiforme: A therapeutic proposal for a chronic disease.
    Dias de Oliveira NF; Miyamoto D; Maruta CW; Aoki V; Santi CG
    J Dermatol; 2021 Oct; 48(10):1569-1573. PubMed ID: 34223646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of antiviral-resistant recurrent erythema multiforme with dapsone.
    Oak AS; Seminario-Vidal L; Sami N
    Dermatol Ther; 2017 Mar; 30(2):. PubMed ID: 27860166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Erythema multiforme. A heterogeneous pathologic phenotype].
    Carrozzo M; Togliatto M; Gandolfo S
    Minerva Stomatol; 1999 May; 48(5):217-26. PubMed ID: 10434539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thalidomide as elective treatment in persistent erythema multiforme; report of two cases.
    Conejo-Mir JS; del Canto S; Muñoz MA; Rodríguez-Freire L; Serrano A; Hernandez C; Pulpillo A
    J Drugs Dermatol; 2003 Jan; 2(1):40-4. PubMed ID: 12852380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent erythema multiforme treated with thalidomide.
    Chen CW; Tsai TF; Chen YF; Hung CM
    Am J Clin Dermatol; 2008; 9(2):123-7. PubMed ID: 18284267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythema multiforme associated with anti-plakin antibodies: a multicentric retrospective case series.
    Weill A; Descamps V; Chasset F; Mahévas T; Bourgault-Villada I; Wolkenstein P; Chollet-Martin S; Ingen-Housz-Oro S; Grootenboer-Mignot S
    J Eur Acad Dermatol Venereol; 2022 Dec; 36(12):2438-2442. PubMed ID: 35607912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.